Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Tecan Group Ltd    TECN   CH0012100191

TECAN GROUP LTD (TECN)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
07/09/2018 07/10/2018 07/11/2018 07/12/2018 07/13/2018 Date
245.6(c) 248(c) 248(c) 251(c) 251(c) Last
23 908 43 768 19 050 17 294 23 387 Volume
-0.16% +0.98% 0.00% +1.21% 0.00% Change
More quotes
Financials (CHF)
Sales 2018 579 M
EBIT 2018 89,2 M
Net income 2018 75,9 M
Finance 2018 359 M
Yield 2018 0,87%
Sales 2019 612 M
EBIT 2019 98,5 M
Net income 2019 84,0 M
Finance 2019 426 M
Yield 2019 0,96%
P/E ratio 2018 38,47
P/E ratio 2019 34,48
EV / Sales2018 4,48x
EV / Sales2019 4,12x
Capitalization 2 952 M
More Financials
Company
Tecan Group AG is a holding company, which engages in the development, production, and distribution of laboratory instruments and solutions in biopharmaceuticals, forensics and clinical diagnostics.It operates through the Life Sciences Business and Partnering Business segments.The Life Sciences... 
Sector
Office Equipment
Calendar
08/16Earnings Release
More about the company
Surperformance© ratings of Tecan Group Ltd
Trading Rating : Investor Rating :
More Ratings
Latest news on TECAN GROUP LTD
07/12TECAN : Are we nearly there yet? Past, present, and future of sample management
PU
07/12TECAN : Three ways an automated microplate reader cuts costs of live cell resear..
PU
07/05TECAN : Live cell assays - six things your cells would tell you if they could ta..
PU
06/26TECAN : The next giant in genome sequencing? China
PU
06/20ROCKING PRODUCTIVITY IN THE GENOMICS : 4 real-world examples
PU
06/12LIQUID HANDLING IN A REGULATED LAB : 5 automation must-haves
PU
06/07BUTTERFLY DISEASE : important lessons from a rare disease research
PU
06/05TECAN : Six questions to ask when automating your drug discovery workflow for gr..
PU
05/31TECAN : Master the challenges of cell-based fluorescence assays
PU
05/29TECAN : Five critical reasons rare diseases deserve research attention now
PU
More news
Sector news : Scientific & Precision Equipment
07/13FUJIFILM : Xerox explores sale of leasing finance unit - sources
RE
07/10FUJIFILM : Fuji Xerox chief sees no breakup of Fujifilm-Xerox JV
RE
06/27FUJIFILM : threatens to compete against Xerox if partnership not renewed
RE
06/26XEROX : CEO Criticizes Fujifilm Suit -- WSJ
DJ
06/19CARL ICAHN : Fujifilm Sues Xerox Following Canceled Merger -- WSJ
DJ
More sector news : Scientific & Precision Equipment
Latest Tweets
07/12Tecan : Three ways an automated microplate reader cuts costs of live cell res.. 
07/05Tecan : Live cell assays - six things your cells would tell you if they could.. 
06/13Andrew Alliance raises $14 mln from Tecan Group, Waters Corp., Inpeco, Rancil.. 
06/05Tecan : Six questions to ask when automating your drug discovery workflow for.. 
05/31Tecan : Master the challenges of cell-based fluorescence assays  
More tweets
Qtime:45
Chart TECAN GROUP LTD
Duration : Period :
Tecan Group Ltd Technical Analysis Chart | TECN | CH0012100191 | 4-Traders
Technical analysis trends TECAN GROUP LTD
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 220  CHF
Spread / Average Target -12%
EPS Revisions
Managers
NameTitle
David Roy Martyr Chief Executive Officer
Lukas Braunschweiler Chairman
Ulrich Kanter EVP, Head-Development & Operations Division
Rudolf Eugster Chief Financial Officer
Heinrich Fischer Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
TECAN GROUP LTD23.83%2 945
CANON INC-16.64%42 026
FUJIFILM HOLDINGS CORP-7.82%19 860
SEIKO EPSON CORPORATION-27.21%6 915
RICOH CO LTD-4.63%6 693
XEROX CORP-13.31%6 446